심장내과 썸네일형 리스트형 First look at the new 2018 European Guidelines for the treatment of high blood pressure 고혈압 치료를 위한 새로운 유럽 가이드라인의 첫 소개는 2018 년 6 월 9 일 바르셀로나에서 열린 유럽 고혈압 학회 (European Society of Hypertension meeting)에서 발표되었습니다.이 오랫동안 기다려온 가이드라인은 유럽 심장 학회 (European Society of Cardiology) (ESC ) 및 유럽 고혈압 학회 (ESH) 합동으로 개발되었습니다. 이 지침은 고혈압을 진단하고, 위험을 평가하고, 고혈압을 치료하고 위험을 줄이는 방법과 시기에 대해 유럽 전역의 의사에게 생활 습관 상담 및 약물 치료와 함께 권고 사항을 제공합니다. 가이드라인의 개발은 영국 런던의 Bryan Williams 교수(ESC 위원장)와 이탈리아 밀라노의 Giuseppe Mancia 교수(.. 당뇨병 환자에서 고혈압 치료, Treatment of Hypertension in Patients With DM BP control is more difficult to achieve in patients with DM than in those without DM, necessitating use of combination therapy in the majority of patients . All major antihypertensive drug classes (i.e., ACE inhibitors, ARBs, CCBs, and diuretics) are useful in the treatment of hypertension in DM. However, in ALLHAT, doxazosin was clearly inferior to chlorthalidone, which also reduced some events.. 말초 동맥 질환 환자에서 고혈압 치료, Treatment of Hypertension in Patients With PAD Recommendation-Specific Supportive Text There is no major difference in the relative risk reduction in CVD from BP-lowering therapy between patients with hypertension and PAD and patients without PAD. There is also no evidence that any one class of antihypertensive medication or strategy is superior. In the INVEST (International Verapamil-Trandolapril) study, the beta blocker atenolol (with or w.. 심방 세동 환자에서 고혈압 치료, Treatment of Hypertension in Patients With AF Recommendation-Specific Supportive Text Although RAS blockade in theory is the treatment of choice for hypertension in patients with prior AF, relative to other classes of agents, all of the trials that have shown clinical superiority of ARBs over other agents were comparisons with CCBs or beta blockers that are no longer recommended as first-line agents for treatment of hypertension. There are .. 당뇨가 있는 고혈압 환자의 치료, Treatment of Hypertension in Patients With DM 2017 High Blood Pressure Clinical Practice Guideline 말초동맥질환이 있는 고혈압 환자의 치료, Treatment of Hypertension in Patients With PAD Recommendation-Specific Supportive Text There is no major difference in the relative risk reduction in CVD from BP-lowering therapy between patients with hypertension and PAD and patients without PAD. There is also no evidence that any one class of antihypertensive medication or strategy is superior . In the INVEST (International Verapamil-Trandolapril) study, the beta blocker atenolol (with or .. 뇌졸중 2차 예방, 고혈압 치료, Treatment of Hypertension for Secondary Stroke Prevention Recommendation-Specific Supportive Text 1. Two overviews of RCTs published through 2009 showed that antihypertensive medications lowered the risk of recurrent vascular events in patients with stroke or TIA. 2. Specific agents that have shown benefit in either dedicated RCTs or systematic reviews of RCT data include diuretics, ACE inhibitors, and ARBs. 3. Support for this recommendation is based .. 급성 뇌경색 환자에서 혈압 조절, Management of Hypertension in Patients With Acute Ischemic Stroke Synopsis Elevated BP is common during acute ischemic stroke (occurring in up to 80% of patients), especially among patients with a history of hypertension. However, BP often decreases spontaneously during the acute phase of ischemic stroke, as soon as 90 minutes after the onset of symptoms. Countervailing theoretical concerns about arterial hypertension during acute ischemic stroke include aimin.. 이전 1 ··· 47 48 49 50 51 52 53 ··· 59 다음
